SCHEMBL479832

SCHEMBL479832

NC(=CC(=O)O)Nc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 2/20 0.52
▸ TSHR P16473 2/20 0.52
▸ EPHX1 P07099 1/20 0.52
▸ EPHX2 P34913 1/20 0.52
▸ CDK9 P50750 1/20 0.52
▸ SMN1; SMN2 Q16637 1/20 0.52
▸ CLK4 Q9HAZ1 1/20 0.52
▸ MAPT P10636 2/20 0.52
▸ GAA P10253 1/20 0.52
▸ GFER P55789 1/20 0.52
▸ TGM2 P21980 2/20 0.48
▸ HSD17B10 Q99714 2/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ TYR P14679 1/20 0.48
▸ TAS2R38 P59533 1/20 0.48
▸ NAPRT Q6XQN6 1/20 0.48
▸ PARP1 P09874 1/20 0.47
▸ KDM1A O60341 1/20 0.47
▸ PTPN1 P18031 1/20 0.47
▸ PLAU P00749 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL479830 1.00 TP53 (0.52) TP53TSHREPHX1EPHX2CDK9
SCHEMBL3078893 0.88 TP53 (0.52) TP53TSHREPHX1EPHX2CDK9
SCHEMBL3078896 0.88 TP53 (0.52) TP53TSHREPHX1EPHX2CDK9
SCHEMBL4318168 0.81 NPC1 (0.59) SMN1; SMN2MAPTGAATGM2HSD17B10
SCHEMBL4318165 0.81 NPC1 (0.59) SMN1; SMN2MAPTGAATGM2HSD17B10
SCHEMBL3077709 0.79 ALDH1A1 (0.59) TP53TSHREPHX1MAPTGAA
SCHEMBL3077704 0.79 ALDH1A1 (0.59) TP53TSHREPHX1MAPTGAA
SCHEMBL14482453 0.78 EPHX1 (0.50) TP53TSHREPHX1EPHX2CDK9
SCHEMBL11772923 0.78 MAPT (0.56) TP53TSHREPHX1EPHX2CDK9
SCHEMBL11772931 0.78 MAPT (0.56) TP53TSHREPHX1EPHX2CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2411367-A1 ANTICANCER DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF SANOFI (FR) 2012-02-01 — — EP disclosed
WO-2010109123-A1 ANTICANCER DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2010-09-30 — — WO disclosed
Send feedback